|
The initial public offer (IPO) of Nephro Care received bids for 5,12,49,600 shares as against 45,84,000 shares on offer, as per NSE data as of 17:00 hours on Friday (28 June 2024). The issue was subscribed 11.18 times.
The issue opened for bidding on Friday (28 June 2024) and it will close on Tuesday (02 July 2024). The price band of the IPO is fixed between Rs 85 to Rs 90 per share. The minimum order quantity is 1,600 equity shares. The equity shares will list on NSE’s SME platform.
The IPO comprises fresh issue of 45,84,000 equity shares. The promoter and promoter group shareholding will dilute to 61.39% from 85.02% pre-issue.
About 2,30,400 equity shares will be reserved for subscription by market maker to the issue and 2,25,600 equity shares will be reserved for eligible employees of the company. The net issue comprises of 41,28,000 equity shares. The issue and the net issue will constitute 27.80% and 25.04% respectively of the post offer paid up equity share capital of the company.
The company intends to utilize the net proceeds for setting up a multi-speciality hospital in the name of Vivacity Multi Specialty Hospital (unit of Nephro Care) at Kolkata (Madhyamgaram), West Bengal and general corporate purpose.
Ahead of the IPO, Nephro Care on Thursday, 27 June 2024, raised Rs 11.14 crore from anchor investors. The board allotted 12.38 lakh shares at Rs 90 per share to 3 anchor investors.
Nephro Care is a one stop treatment centre based in Kolkata that offers a wide range of clinical and lifestyle solutions and services and renal insufficiency treatment to patients. The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness. The operations of the company were supported by a pool of expert Doctors, experienced and well-trained paramedical professionals and a skilled management team. In December 2021, the company set up its own daycare unit at JC-18, Salt Lake in Kolkata with facilities for offering a wide range of services. Currently the company offers service which includes Inhouse Dialysis Unit, Outpatient Services in areas of Nephrology, Diabetology, Cardiology, Ophthalmology and Neurology, NABL accredited inhouse Pathology, Inhouse Pharmacy, Advance diagnostic facilities, Renal Nutrition department, Home Care The company has total 127 employees.
The company recorded revenue from operations of Rs 19.75 crore and net profit of Rs 3.40 crore for the nine month ended on 31 December 2023.
|